Revvity Health NBS Reagents and Service

Background
The contract is issued by the Newborn Screening Program (NBS) under the Colorado Department of Public Health and Environment (CDPHE). The NBS Program is mandated by state statute and Board of Health requirements to conduct testing on all infants born in Colorado. This contract aims to procure reagents and services from Revvity Health Sciences Inc., which are essential for the operation of the NBS program.

Work Details
The contract involves the rental of reagents, instrumentation, and supplies necessary for conducting newborn screening tests. Revvity's instruments and reagents are specifically designed to meet CLIA and FDA requirements. The estimated dollar amount for the life of the project is $9,700,000, with a modification increasing this to $10,120,000 due to an unexpected rise in births leading to increased reagent usage. The reagents provided are proprietary to Revvity and are critical for maintaining uninterrupted service in newborn screening.

Period of Performance
The contract period runs from February 15, 2021, to February 14, 2026.

Place of Performance
The services will be performed in Colorado as part of the Newborn Screening Program.

Bidder Requirements
Revvity Health Sciences Inc. is identified as the sole source vendor due to their unique position as the only manufacturer and distributor of the required reagents compatible with their instrumentation. No other vendors can provide equivalent products without significant additional costs or operational disruptions.